BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 15451794)

  • 1. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient.
    Fichtlscherer S; Breuer S; Zeiher AM
    Circulation; 2004 Oct; 110(14):1926-32. PubMed ID: 15451794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-10 serum levels and systemic endothelial vasoreactivity in patients with coronary artery disease.
    Fichtlscherer S; Breuer S; Heeschen C; Dimmeler S; Zeiher AM
    J Am Coll Cardiol; 2004 Jul; 44(1):44-9. PubMed ID: 15234404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic endothelial dysfunction as an early predictor of adverse outcome in heart failure.
    Heitzer T; Baldus S; von Kodolitsch Y; Rudolph V; Meinertz T
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1174-9. PubMed ID: 15831810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial dysfunction in patients with recent myocardial infarction and hyperhomocysteinaemia: effects of vitamin supplementation.
    Chia S; Wilson R; Ludlam CA; Webb DJ; Flapan AD; Newby DE
    Clin Sci (Lond); 2005 Jan; 108(1):65-72. PubMed ID: 15367100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes.
    Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B
    Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.
    Heeschen C; Dimmeler S; Hamm CW; Fichtlscherer S; Simoons ML; Zeiher AM;
    J Am Coll Cardiol; 2005 Jan; 45(2):229-37. PubMed ID: 15653020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease.
    Shechter M; Issachar A; Marai I; Koren-Morag N; Freinark D; Shahar Y; Shechter A; Feinberg MS
    Int J Cardiol; 2009 May; 134(1):52-8. PubMed ID: 18479768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of atorvastatin on impaired vascular function in healthy old men.
    Weverling-Rijnsburger AW; Blauw GJ; Meinders AE
    J Clin Pharm Ther; 2004 Apr; 29(2):157-64. PubMed ID: 15068405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease.
    Fichtlscherer S; Dimmeler S; Breuer S; Busse R; Zeiher AM; Fleming I
    Circulation; 2004 Jan; 109(2):178-83. PubMed ID: 14662709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein: the underlying cause of microvascular dysfunction in rheumatoid arthritis.
    Galarraga B; Khan F; Kumar P; Pullar T; Belch JJ
    Rheumatology (Oxford); 2008 Dec; 47(12):1780-4. PubMed ID: 18854346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidized LDL and small LDL particle size are independently predictive of a selective defect in microcirculatory endothelial function in type 2 diabetes.
    Woodman RJ; Watts GF; Playford DA; Best JD; Chan DC
    Diabetes Obes Metab; 2005 Sep; 7(5):612-7. PubMed ID: 16050955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute administration of caffeine on vascular function.
    Umemura T; Ueda K; Nishioka K; Hidaka T; Takemoto H; Nakamura S; Jitsuiki D; Soga J; Goto C; Chayama K; Yoshizumi M; Higashi Y
    Am J Cardiol; 2006 Dec; 98(11):1538-41. PubMed ID: 17126666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between vascular dysfunction and cardiac mass increases the risk of cardiovascular outcomes in essential hypertension.
    Sciacqua A; Scozzafava A; Pujia A; Maio R; Borrello F; Andreozzi F; Vatrano M; Cassano S; Perticone M; Sesti G; Perticone F
    Eur Heart J; 2005 May; 26(9):921-7. PubMed ID: 15689344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients.
    Chiang KH; Huang PH; Huang SS; Wu TC; Chen JW; Lin SJ
    Coron Artery Dis; 2009 Jun; 20(4):267-73. PubMed ID: 19440065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular insulin response is preserved in non-diabetic patients with coronary artery disease, despite endothelial dysfunction.
    Ihlemann N; Rask-Madsen C; Køber L; Torp-Pedersen C
    Scand Cardiovasc J; 2004 Mar; 38(1):22-7. PubMed ID: 15204243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetition of ischemic preconditioning augments endothelium-dependent vasodilation in humans: role of endothelium-derived nitric oxide and endothelial progenitor cells.
    Kimura M; Ueda K; Goto C; Jitsuiki D; Nishioka K; Umemura T; Noma K; Yoshizumi M; Chayama K; Higashi Y
    Arterioscler Thromb Vasc Biol; 2007 Jun; 27(6):1403-10. PubMed ID: 17446439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes.
    Willoughby SR; Stewart S; Holmes AS; Chirkov YY; Horowitz JD
    Arterioscler Thromb Vasc Biol; 2005 Dec; 25(12):2661-6. PubMed ID: 16254202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
    Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
    Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.